Fluorodeoxyglucose-PET in Melanoma and Soft-Tissue Sarcoma: Current Applications, Challenges, and Future Directions

Sambit Sagar1, Dikhra Khan1, Nivedita Kundu2

  • 1Department of Nuclear Medicine, All India Institute of Medical Sciences (AIIMS CAPFIMS), New Delhi, India.

PET Clinics
|July 30, 2026
PubMed
Summary

Fluorodeoxyglucose PET/CT is crucial for managing melanoma and soft-tissue sarcoma, aiding in staging and treatment assessment. Advanced techniques like radiomics and AI are enhancing its role in personalized cancer care.